Navigation Links
Soap and Water May not be Enough to Fight MRSA Superbug
Date:11/8/2007

has the potential to become life threatening when it enters the body through scrapes and scratches, potentially leading to blood and joint infections, pneumonia and even death.

A key to prevention of a MRSA infection is keeping hands clean to reduce the risk of cross-contamination. However, many of the products used by consumers do not contain antimicrobial agents that provide extended antimicrobial action. They may not kill MRSA on contact and provide up to six hours of residual, or ongoing protection, such as CHG found in the cleanser Hibiclens(R) and convenient Hibistat(R) Germicidal Towelettes, according to Twomey.

Residual activity works when the antimicrobial remains active on the skin for a period of time after use. For hand cleansers, this means the antimicrobial continues to kill germs for an extended period of time after washing. Alcohol is a common hand antiseptic and is extremely effective for immediate kill. However, when alcohol dries, the germ-killing action stops. The next contaminated object touched will recontaminate the hand.

Containing CHG, both Hibiclens and Hibistat have been proven to provide fast-acting, antimicrobial protection. They kill a broad spectrum of harmful organisms, continuing to fight germs much longer than soap and water or

alcohol alone. Hibistat Towelettes work without water and contain a quick- drying formula with added emollients, making them safe for frequent daily use.

The Citadel, a well-known military college in Charleston, S.C., has been successfully using Hibiclens for more than 10 years in its Sports Medicine Department to lessen the severity of infections and help prevent the spread of germs such as those associated with MRSA and other staph-related bacteria. The Navy Environmental Health Center(3) also recommends the use of CHG in prevention of MRSA.

"We found that Hibiclens helps prevent the severity of MRSA-related infections, if caught in the early stages," said Craig Clark, Th
'/>"/>

SOURCE Molnlycke Health Care US, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Discover Testing Settles the Drinking Water Debate: Tap vs. Bottled
2. AspenBio Pharma to Present the Edgewater Research Investor Conference
3. Novel gate dielectric materials: perfection is not enough
4. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
5. Superbugs, shapes and nanotechnology
6. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 According ... “Consolidation continues to reshape the look and feel of ... Consumer demand for higher-quality ingredients will push for more ... American market have experienced strong market growth in the ... attributes in their food and cosmetics to fit a ...
(Date:8/26/2014)... 26, 2014  NeuroSigma, Inc., a Los ... bioelectronic technologies, today announced that it has filed a ... and Exchange Commission relating to a proposed initial public ... to be offered and the price range for the ... Jefferies LLC will act as the book-running manager for ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... Greater Baltimore,Committee is seeking nominations for the Third ... on Tuesday, March 18, 2008. Those,interested in nominating ... http://www.gbc.org ., The four award categories are: ... and President,s Award. Nominators will,be asked to submit ...
... Jan. 14 VIRxSYS Corporation, a,privately held company ... Lentigen Corporation, a privately-owned biotechnology company,focused on the ... they have agreed to settle the pending litigation ... claims and counterclaims,asserted in the lawsuit, which has ...
... Company Accelerating Efforts to Commercialize Bio-Based Technologies to ... ... DuPont (NYSE: DD ),has named Nicholas C. Fanandakis group ... Fanandakis will lead the,company,s accelerated efforts to commercialize a range ...
Cached Biology Technology:VIRxSYS and Lentigen Announce Litigation Settlement 2DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences 2
(Date:8/27/2014)... beasts. But every creature is a baby once. , ... of 24 very young dinosaurs and one older individual ... a caretaker, according to a new study by University ... Peter Dodson led the work, collaborating with researchers from ... is held. Hedrick is a doctoral student in the ...
(Date:8/27/2014)... rare, but deadly disease that exists as five strains, ... most lethal strains is the Sudan ebolavirus (SUDV). Although ... caused widespread illness, even as recently as 2012. In ... Chemical Biology , researchers now report a possible therapy ... , John Dye, Sachdev Sidhu, Jonathan Lai and colleagues ...
(Date:8/27/2014)... the long-standing belief that a deficiency in serotonin ... central role in depression. In the journal ACS ... ability to make serotonin in their brains (and thus ... show depression-like symptoms. , Donald Kuhn and colleagues ... Wayne State University School of Medicine note that depression ...
Breaking Biology News(10 mins):Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2New study throws into question long-held belief about depression 2
... a gene for a specific protein face a 20-fold greater ... in mBio , the online open-access journal of the ... is the most common cause of fungal meningitis among HIV-infected ... HIV who has a very low level of CD4+ T ...
... at the Medical College of Wisconsin (MCW) have developed ... identify genetic mutations responsible for cancers.The tool, called DrGaP, ... the American Journal of Human Genetics . ... National Cancer Institute, and a former visiting scholar at ...
... FASEB MARC (Maximizing Access to Research Careers) Program ... Writing Seminar and Practical Exercises Workshop at the Marine ... 2012. Awards are given to graduate students, postdocs and ... have never written a successful grant application. This year ...
Cached Biology News:Gene makes some HIV-infected patients more at risk for fungal disease 2Gene makes some HIV-infected patients more at risk for fungal disease 3
Request Info...
... Nuclease catalyzes the degradation of single-stranded DNA ... products. While the nuclease prefers ssDNA over ... the enzyme degrades double-stranded DNA from both ... used for transcript mapping studies (3,4), for ...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
...
Biology Products: